Imprimis recalls specific epinephrine-lidocaine vials for intraocular use due to lack of sterility assurance. These vials may cause infection if used improperly.
Lack of Assurance of Sterility
Imprimis is recalling epinephrine-lidocaine vials for eye injections because they lack sterility assurance. Using these vials could lead to infections if they are not properly sterilized before use.
The vials lack sterility assurance, meaning they may not be clean enough for eye injections. This could lead to infections if used without proper sterilization.
People who own or use these vials for eye injections. Those with medical conditions requiring frequent eye injections are at higher risk.
Check for NDC 71384-640-01 with lot numbers 23APR033 (expiring 5/1/24) or 23JUN001 (expiring 6/5/24).
Verify the expiration date on the vial label to ensure it is not past the expiration date.
The recall states there is a lack of sterility assurance, so they are not safe for eye injections without proper sterilization.
The recall does not specify a remedy, so contact Imprimis directly for guidance.
Look for NDC 71384-640-01 with lot numbers 23APR033 (expiring 5/1/24) or 23JUN001 (expiring 6/5/24).
We’ve drafted a message you can send Imprimis to request your refund or repair — edit it as you like.
Subject: Recall D-0512-2024 — Imprimis Imprimis Hello, I own a Imprimis that is covered by recall D-0512-2024 from Imprimis. I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this? Thank you.
Experiences, tips, and questions from readers. Every comment is reviewed before it appears.
No comments yet — be the first to share your experience.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
